Clapper Caskie Lewis Sells 59,313 Shares of Magellan Health Inc (MGLN) Stock

Magellan Health Inc (NASDAQ:MGLN) insider Clapper Caskie Lewis sold 59,313 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $93.99, for a total value of $5,574,828.87. Following the transaction, the insider now directly owns 48,474 shares in the company, valued at approximately $4,556,071.26. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of Magellan Health Inc (MGLN) opened at $96.40 on Thursday. Magellan Health Inc has a 52 week low of $64.05 and a 52 week high of $96.85. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.21 and a current ratio of 2.28. The stock has a market capitalization of $2,290.03, a price-to-earnings ratio of 21.70, a P/E/G ratio of 1.22 and a beta of 0.54.

Magellan Health (NASDAQ:MGLN) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.40 by $0.24. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.49 billion. Magellan Health had a return on equity of 9.20% and a net margin of 1.68%. The business’s revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.39 EPS. equities analysts expect that Magellan Health Inc will post 5.19 EPS for the current fiscal year.

Several large investors have recently bought and sold shares of MGLN. Vanguard Group Inc. boosted its holdings in shares of Magellan Health by 3.3% during the 2nd quarter. Vanguard Group Inc. now owns 2,189,293 shares of the company’s stock valued at $159,600,000 after purchasing an additional 70,806 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Magellan Health by 0.3% during the second quarter. Dimensional Fund Advisors LP now owns 1,991,351 shares of the company’s stock valued at $145,170,000 after buying an additional 6,046 shares during the period. Northern Trust Corp boosted its stake in Magellan Health by 7.7% in the second quarter. Northern Trust Corp now owns 751,341 shares of the company’s stock valued at $54,773,000 after acquiring an additional 53,434 shares in the last quarter. State Street Corp lifted its stake in shares of Magellan Health by 2.6% during the second quarter. State Street Corp now owns 691,484 shares of the company’s stock worth $50,404,000 after buying an additional 17,198 shares during the period. Finally, LSV Asset Management purchased a new position in shares of Magellan Health during the second quarter worth $44,282,000. Hedge funds and other institutional investors own 94.96% of the company’s stock.

MGLN has been the topic of several recent analyst reports. Jefferies Group reaffirmed a “buy” rating and set a $94.00 price target on shares of Magellan Health in a research report on Friday, October 13th. ValuEngine upgraded Magellan Health from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. KeyCorp reiterated a “buy” rating and set a $89.00 target price on shares of Magellan Health in a research note on Friday, September 22nd. Zacks Investment Research downgraded Magellan Health from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Finally, Raymond James Financial restated a “hold” rating on shares of Magellan Health in a research note on Saturday, December 2nd. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $90.50.

TRADEMARK VIOLATION WARNING: This piece was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3078809/clapper-caskie-lewis-sells-59313-shares-of-magellan-health-inc-mgln-stock.html.

Magellan Health Company Profile

Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).

Insider Buying and Selling by Quarter for Magellan Health (NASDAQ:MGLN)

Receive News & Ratings for Magellan Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.